Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Depression: Overview

Depression: Overview

Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...

Depressive Disorders: MDD and Dysthymia

Depressive Disorders: MDD and Dysthymia

Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...

Acute Coronary Syndrome IV: Interprofessional Care

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

Antidepressant Drugs: Overview

Antidepressant Drugs: Overview

Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...

Long-term Depression

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...

Long-term Depression

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Factors associated with interpersonal retraumatization in children and adolescents: A prospective study.

Psychiatry research·2025

Same author

Chronic Pain, Hopelessness, and Suicide Risk Among Adult Medical Inpatients.

Journal of the Academy of Consultation-Liaison Psychiatry·2023

Same author

Reward Behavior Disengagement, a Neuroeconomic Model-Based Objective Measure of Reward Pathology in Depression: Findings from the EMBARC Trial.

Behavioral sciences (Basel, Switzerland)·2023

Same author

Intranasal esketamine effectively treats treatment-resistant depression in adults regardless of baseline irritability.

Journal of affective disorders·2022

Same author

Longitudinal Course of Adverse Events With Esketamine Nasal Spray: A Post Hoc Analysis of Pooled Data From Phase 3 Trials in Patients With Treatment-Resistant Depression.

The Journal of clinical psychiatry·2022

Same author

Montgomery-Åsberg Depression Rating Scale factors in treatment-resistant depression at onset of treatment: Derivation, replication, and change over time during treatment with esketamine.

International journal of methods in psychiatric research·2022

Search research articles

Related Experiment Video

Updated: Jun 20, 2026

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis

Published on: May 10, 2022

A computerized decision support system for depression in primary care.

Benji T Kurian¹, Madhukar H Trivedi, Bruce D Grannemann

¹Department of Psychiatry, The University of Texas Southwestern Medical Center, Dallas.

Primary Care Companion to the Journal of Clinical Psychiatry

|September 15, 2009

Summary

This summary is machine-generated.

A computerized decision support system (CDSS) improved major depressive disorder (MDD) treatment outcomes in primary care. This CDSS demonstrated superior efficacy compared to usual care, showing greater symptom reduction in patients with MDD.

More Related Videos

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

Related Experiment Videos

Last Updated: Jun 20, 2026

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis

A Computer-Based Platform for Aiding Clinicians in Eating Disorder Analysis and Diagnosis

Published on: May 10, 2022

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

Area of Science:

Clinical Informatics
Psychiatry
Primary Care Medicine

Background:

The Texas Medication Algorithm Project (TMAP) previously showed improved outcomes for major depressive disorder (MDD) when physicians adhered to its algorithm.
Physician adherence and implementation of the TMAP algorithm were found to be inadequate.
A computerized decision support system (CDSS) was developed to enhance adherence and fidelity to the TMAP algorithm for depression.

Purpose of the Study:

To evaluate the feasibility and efficacy of a CDSS for assisting primary care physicians in treating patients with MDD.
To compare the effectiveness of CDSS-assisted treatment versus usual care for acute MDD treatment in primary care.

Main Methods:

A 2-group, parallel-design clinical trial was conducted at two primary care clinics.
Fifty-five patients diagnosed with MDD (DSM-IV criteria) were enrolled and randomized into two groups: CDSS-assisted treatment (32 patients) and usual care (23 patients).
Depression symptom severity was assessed using the 17-item Hamilton Depression Rating Scale (HDRS(17)) by an independent rater.

Main Results:

Patients treated by physicians using the CDSS experienced significantly greater reduction in depression symptoms compared to those receiving usual care (P < .001).
The HDRS(17) scores indicated superior outcomes for the CDSS group.

Conclusions:

The CDSS, incorporating measurement-based care, proved superior to usual care for treating MDD patients in primary care settings.
Larger randomized controlled trials are recommended to validate these findings and confirm the efficacy of the CDSS for MDD treatment.